InvestorsHub Logo
Followers 0
Posts 30
Boards Moderated 0
Alias Born 02/25/2019

Re: None

Monday, 03/04/2019 2:29:58 PM

Monday, March 04, 2019 2:29:58 PM

Post# of 43784
@ response rate thread

Fasco,

The one strong point about response rate method is in this link:

https://ecancer.org/news/15170-immunotherapy-keeps-some-patients-with-advanced-head-and-neck-cancer-alive-for-more-than-three-years.php

The article says when an cancer patient responds to an immune system drug, then the patient responds a large amount.

This is very consistent with the CVM Phase 2 where 8 of 19 patients responded to Multikine and 2 of the 8 had their tumor vanish in 3 weeks.

This is also positive for Phase 3 because a lot of the patients responding will live to the 36 month endpoint and longer after that, too.

I still think the spreadsheet is the primary method to make an educated guess on Phase 3 meeting endpoint, but the response rate method does at least confirm how tumors can vanish and/or become 50% smaller in 3 weeks with Multikine.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News